Increased platelet expression of glycoprotein IIIa following aspirin treatment in aspirin-resistant but not aspirin-sensitive subjects

AIMS: Aspirin is widely used as an anti-platelet agent for cardiovascular prophylaxis. Despite aspirin treatment, many patients experience recurrent thrombotic events, and aspirin resistance may contribute to this. We examined the prevalence of aspirin resistance in a healthy population, and investi...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Floyd, Christopher N, Goodman, Timothy, Becker, Silke, Chen, Nan, Mustafa, Agnesa, Schofield, Emma, Campbell, James, Ward, Malcolm, Sharma, Pankaj, Ferro, Albert
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Blackwell Science Inc 2014
Gaiak:
Pharmacodynamics
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4137824/
https://ncbi.nlm.nih.gov/pubmed/25099258
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.12335
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak